REGN4659
R4659-ONC-1795
Phase 1 small_molecule terminated
Quick answer
REGN4659 for Carcinoma, Non-Small-Cell Lung is a Phase 1 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated